ChemDiv, a global provider of integrated drug discovery solutions, today announced the extension of its Chemistry, Manufacturing and Controls (CMC) services collaboration supporting the clinical ...
Differentiated profile of ALY-301 designed to enable chronic dosing in mast cell dependent diseases while avoiding the safety limitations of conventional c-Kit inhibitors -- Multicenter Phase 1/1b ...
Incyte (Nasdaq:INCY) today announced that data from key programs in its oncology portfolio will be presented in both oral and poster sessions at the 2025 American Society of Hematology (ASH) Annual ...
Alys Pharmaceuticals has announced the dosing of the first subject in its phase 1/1b trial of ALY-301, a first-in-class mast ...
DistillerSR's literature review platform to provide turn-key integrated access to Embase' API, greatly enhancing and simplifying the review process OTTAWA, ONTARIO / ACCESS Newswire / November 4, 2025 ...
Still, human data is more nuanced. “While the evidence that the gut microbiome affects mood is relatively strong, evidence ...
The U.S. Food and Drug Administration is reviewing a new Parkinson's disease drug called tavapadon that could give people ...
The LSU Board of Supervisors voted Tuesday to name McNeese State leader Wade Rousse its next system president, and it has picked the University of Alabama Provost Jim Dalton as both chancellor and ...
News-Medical.Net on MSN
Inconsistent labels and risky doses found in turmeric supplements worldwide
A global analysis of 125 turmeric supplements across five major markets revealed widespread inconsistencies in labeling, ...
(GLOBE NEWSWIRE) -- (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its ...
Every month, Emeritus Professor of University History Leen Dorsman describes something you must know about the long history of Utrecht University. This time: labs in Utrecht.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results